FDA Approved: REZUROCK — Original Application (Kadmon Pharmaceuticals, LLC)

View source ↗

Summary

The FDA approved REZUROCK (belumosudil) from Kadmon Pharmaceuticals, LLC as an original NDA for the treatment of adults with chronic graft-versus-host disease w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• REZUROCK (belumosudil)

Snippet

ORIG AP for REZUROCK (BELUMOSUDIL)